PICU admission at diagnosis as a practical indicator of severe hemorrhagic presentation in pediatric acute promyelocytic leukemia: a 20-year single-center experience

Background Acute promyelocytic leukemia (APL) is highly curable in children, yet early hemorrhagic mortality remains the main barrier to cure, particularly in Sanz high-risk disease. Pediatric data from the Middle East and North Africa (MENA) region are scarce, and predictors of intensive-care need at diagnosis are uncharacterized. We characterized the presentation, outcomes, and ATRA/ATO toxicity in a pediatric APL series and identified features associated with pediatric intensive care unit (PICU) admission. Methods We conducted an exploratory single-center retrospective review of PML::RARA-confirmed pediatric APL patients at King Hussein Cancer Center (KHCC), 2006–2026 (N = 19 evaluable). Complete remission (CR), early death, relapse, and minimal residual disease (MRD) negativity were reported descriptively; overall survival (OS) and event-free survival (EFS) were estimated by the Kaplan–Meier method and compared by Sanz risk and treatment era. PICU admission was evaluated against severity markers using Fisher's exact test. Results Nineteen patients were identified (male 52.6%; median age 9 years); 73.7% had Sanz high-risk disease. Hematologic CR was 94.4%, early death 5.6%, and relapse 11.8%; MRD negativity was 70.6% post-induction and 100% post-consolidation. OS was 94.4% at 24 months and 85.9% at 60 months; EFS fell to 77.9% by 36 months after two relapses, without significant differences by risk or era. Differentiation syndrome occurred in 42.1%, without ATO-related toxicity. PICU admission occurred in 47.4% (9/19); a severity marker was present in 66.7% of PICU-admitted versus 0% of non-PICU patients (p = 0.003). Conclusions In this 20-year KHCC series, survival and remission outcomes were favorable despite a predominantly high-risk population. PICU admission at diagnosis identified all patients presenting with DIC, major hemorrhage, or intracranial hemorrhage. Because these complications are themselves indications for intensive care, PICU status is best regarded as a practical, immediately available indicator of severe presentation rather than an independent prognostic factor, with potential value for early triage and supportive-care planning in resource-limited settings.

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2026-11-20
DOI
https://doi.org/10.3389/fonc.2026.1997498
Primary Topic
Retinoids in leukemia and cellular processes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

PICU admission at diagnosis as a practical indicator of severe hemorrhagic presentation in pediatric acute promyelocytic leukemia: a 20-year single-center experience

Rihani Rawad, Amal Abu Ghosh, Dana Kanaan, Hasan Hashem et al.
4 links
Frontiers in Oncology
Retinoids in leukemia and cellular processes
article

PICU admission at diagnosis as a practical indicator of severe hemorrhagic presentation in pediatric acute promyelocytic leukemia: a 20-year single-center experience

Rihani Rawad, Amal Abu Ghosh, Dana Kanaan, Hasan Hashem, Tala Al Shalakhti, Mayada Abu Shanap
article en

Abstract

Background Acute promyelocytic leukemia (APL) is highly curable in children, yet early hemorrhagic mortality remains the main barrier to cure, particularly in Sanz high-risk disease. Pediatric data from the Middle East and North Africa (MENA) region are scarce, and predictors of intensive-care need at diagnosis are uncharacterized. We characterized the presentation, outcomes, and ATRA/ATO toxicity in a pediatric APL series and identified features associated with pediatric intensive care unit (PICU) admission. Methods We conducted an exploratory single-center retrospective review of PML::RARA-confirmed pediatric APL patients at King Hussein Cancer Center (KHCC), 2006–2026 (N = 19 evaluable). Complete remission (CR), early death, relapse, and minimal residual disease (MRD) negativity were reported descriptively; overall survival (OS) and event-free survival (EFS) were estimated by the Kaplan–Meier method and compared by Sanz risk and treatment era. PICU admission was evaluated against severity markers using Fisher's exact test. Results Nineteen patients were identified (male 52.6%; median age 9 years); 73.7% had Sanz high-risk disease. Hematologic CR was 94.4%, early death 5.6%, and relapse 11.8%; MRD negativity was 70.6% post-induction and 100% post-consolidation. OS was 94.4% at 24 months and 85.9% at 60 months; EFS fell to 77.9% by 36 months after two relapses, without significant differences by risk or era. Differentiation syndrome occurred in 42.1%, without ATO-related toxicity. PICU admission occurred in 47.4% (9/19); a severity marker was present in 66.7% of PICU-admitted versus 0% of non-PICU patients (p = 0.003). Conclusions In this 20-year KHCC series, survival and remission outcomes were favorable despite a predominantly high-risk population. PICU admission at diagnosis identified all patients presenting with DIC, major hemorrhage, or intracranial hemorrhage. Because these complications are themselves indications for intensive care, PICU status is best regarded as a practical, immediately available indicator of severe presentation rather than an independent prognostic factor, with potential value for early triage and supportive-care planning in resource-limited settings.

Frontiers in OncologyVol. 16
King Hussein Cancer Center (JO)
Good health and well-being
Retinoids in leukemia and cellular processes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon